Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 3 | 2023 | 202 | 1.480 |
Why?
|
| Colorectal Surgery | 3 | 2022 | 22 | 1.430 |
Why?
|
| Quality Improvement | 9 | 2023 | 473 | 1.200 |
Why?
|
| Colectomy | 6 | 2024 | 181 | 1.180 |
Why?
|
| Postoperative Complications | 11 | 2023 | 2459 | 1.090 |
Why?
|
| Rectum | 4 | 2023 | 149 | 1.030 |
Why?
|
| Rectal Neoplasms | 3 | 2024 | 133 | 0.940 |
Why?
|
| Risk Assessment | 3 | 2024 | 2370 | 0.920 |
Why?
|
| Analgesics, Opioid | 3 | 2023 | 472 | 0.880 |
Why?
|
| Prescription Drug Misuse | 1 | 2023 | 13 | 0.840 |
Why?
|
| Catastrophization | 1 | 2022 | 8 | 0.780 |
Why?
|
| Colonic Neoplasms | 3 | 2022 | 583 | 0.760 |
Why?
|
| Sexism | 1 | 2022 | 57 | 0.750 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2022 | 134 | 0.730 |
Why?
|
| Anus Diseases | 1 | 2020 | 15 | 0.710 |
Why?
|
| Paget Disease, Extramammary | 1 | 2020 | 8 | 0.690 |
Why?
|
| Colon | 2 | 2021 | 527 | 0.690 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 64 | 0.680 |
Why?
|
| Crohn Disease | 2 | 2020 | 772 | 0.680 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2020 | 48 | 0.670 |
Why?
|
| Anus Neoplasms | 1 | 2020 | 37 | 0.670 |
Why?
|
| Postoperative Care | 2 | 2020 | 239 | 0.650 |
Why?
|
| Insurance Coverage | 1 | 2021 | 134 | 0.650 |
Why?
|
| Home Health Nursing | 1 | 2017 | 2 | 0.550 |
Why?
|
| Patient Selection | 2 | 2022 | 689 | 0.540 |
Why?
|
| Ileostomy | 1 | 2017 | 29 | 0.540 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2021 | 72 | 0.520 |
Why?
|
| Humans | 39 | 2025 | 92352 | 0.510 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 98 | 0.510 |
Why?
|
| Aftercare | 1 | 2017 | 88 | 0.500 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 152 | 0.480 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 611 | 0.480 |
Why?
|
| Pouchitis | 1 | 2015 | 56 | 0.470 |
Why?
|
| Surgeons | 3 | 2024 | 265 | 0.460 |
Why?
|
| Patient Readmission | 2 | 2019 | 393 | 0.430 |
Why?
|
| Surgical Wound Infection | 2 | 2023 | 224 | 0.420 |
Why?
|
| Length of Stay | 5 | 2022 | 798 | 0.380 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 1045 | 0.350 |
Why?
|
| Databases, Factual | 3 | 2021 | 955 | 0.350 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2556 | 0.320 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2023 | 619 | 0.320 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2012 | 283 | 0.320 |
Why?
|
| Colonoscopy | 2 | 2024 | 300 | 0.320 |
Why?
|
| United States | 9 | 2024 | 7349 | 0.300 |
Why?
|
| Perioperative Care | 2 | 2022 | 174 | 0.300 |
Why?
|
| Robotic Surgical Procedures | 2 | 2024 | 342 | 0.300 |
Why?
|
| Retrospective Studies | 9 | 2022 | 9707 | 0.290 |
Why?
|
| Sepsis | 2 | 2023 | 350 | 0.290 |
Why?
|
| Short Bowel Syndrome | 2 | 2022 | 38 | 0.280 |
Why?
|
| Anti-Bacterial Agents | 3 | 2025 | 810 | 0.270 |
Why?
|
| Risk Factors | 6 | 2022 | 5706 | 0.260 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 6918 | 0.260 |
Why?
|
| Laparoscopy | 3 | 2022 | 785 | 0.250 |
Why?
|
| Hospitals | 3 | 2023 | 314 | 0.240 |
Why?
|
| Logistic Models | 2 | 2021 | 1239 | 0.240 |
Why?
|
| Pain, Postoperative | 3 | 2022 | 275 | 0.240 |
Why?
|
| Diverticulitis, Colonic | 1 | 2025 | 12 | 0.240 |
Why?
|
| Middle Aged | 12 | 2024 | 27039 | 0.240 |
Why?
|
| Employee Performance Appraisal | 1 | 2024 | 5 | 0.230 |
Why?
|
| Work Performance | 1 | 2024 | 5 | 0.230 |
Why?
|
| Female | 14 | 2024 | 47908 | 0.220 |
Why?
|
| Aged | 9 | 2024 | 19952 | 0.210 |
Why?
|
| Prescriptions | 1 | 2023 | 26 | 0.210 |
Why?
|
| Male | 13 | 2024 | 43942 | 0.210 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2023 | 40 | 0.210 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 80 | 0.210 |
Why?
|
| Movement | 1 | 2024 | 318 | 0.190 |
Why?
|
| Adult | 9 | 2024 | 27536 | 0.180 |
Why?
|
| Enterostomy | 1 | 2020 | 3 | 0.180 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2020 | 16 | 0.180 |
Why?
|
| Steroids | 1 | 2022 | 173 | 0.180 |
Why?
|
| Fitness Trackers | 1 | 2020 | 6 | 0.180 |
Why?
|
| Ligation | 1 | 2020 | 55 | 0.180 |
Why?
|
| Clinical Alarms | 1 | 2020 | 16 | 0.180 |
Why?
|
| Mental Health | 1 | 2022 | 184 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 1764 | 0.170 |
Why?
|
| Early Ambulation | 1 | 2020 | 30 | 0.170 |
Why?
|
| Leadership | 1 | 2022 | 146 | 0.170 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 32 | 0.170 |
Why?
|
| Organizational Innovation | 1 | 2020 | 42 | 0.170 |
Why?
|
| Acute Disease | 2 | 2025 | 856 | 0.170 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 65 | 0.170 |
Why?
|
| Margins of Excision | 1 | 2020 | 42 | 0.170 |
Why?
|
| Drainage | 1 | 2020 | 170 | 0.160 |
Why?
|
| Anal Canal | 1 | 2020 | 90 | 0.160 |
Why?
|
| Self Care | 1 | 2020 | 169 | 0.160 |
Why?
|
| Foundations | 1 | 2019 | 15 | 0.160 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2020 | 105 | 0.160 |
Why?
|
| Operating Rooms | 1 | 2020 | 134 | 0.160 |
Why?
|
| Referral and Consultation | 1 | 2022 | 353 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 128 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2024 | 807 | 0.150 |
Why?
|
| Clostridium Infections | 1 | 2021 | 125 | 0.150 |
Why?
|
| Quality of Health Care | 1 | 2022 | 390 | 0.150 |
Why?
|
| Simulation Training | 1 | 2020 | 106 | 0.150 |
Why?
|
| Surgical Flaps | 1 | 2020 | 254 | 0.150 |
Why?
|
| Research Support as Topic | 1 | 2019 | 87 | 0.150 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 485 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2019 | 157 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 569 | 0.150 |
Why?
|
| Neoplasm Staging | 2 | 2022 | 2035 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2022 | 424 | 0.150 |
Why?
|
| Biological Products | 1 | 2020 | 171 | 0.150 |
Why?
|
| Cecum | 1 | 2018 | 76 | 0.140 |
Why?
|
| Intestinal Perforation | 1 | 2018 | 36 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2020 | 295 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 866 | 0.140 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 871 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 291 | 0.140 |
Why?
|
| Obesity | 1 | 2024 | 1016 | 0.140 |
Why?
|
| Critical Care | 1 | 2021 | 399 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 709 | 0.140 |
Why?
|
| Suburethral Slings | 1 | 2018 | 77 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 444 | 0.130 |
Why?
|
| Age Factors | 1 | 2021 | 1905 | 0.130 |
Why?
|
| Serum Albumin | 1 | 2016 | 127 | 0.130 |
Why?
|
| Dyspnea | 1 | 2016 | 80 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2017 | 115 | 0.130 |
Why?
|
| Emergencies | 1 | 2016 | 121 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2016 | 337 | 0.130 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2018 | 198 | 0.120 |
Why?
|
| Creatinine | 1 | 2016 | 296 | 0.120 |
Why?
|
| Incidence | 2 | 2019 | 1661 | 0.120 |
Why?
|
| Economics, Hospital | 1 | 2015 | 11 | 0.120 |
Why?
|
| Transanal Endoscopic Surgery | 1 | 2015 | 1 | 0.120 |
Why?
|
| Reimbursement Mechanisms | 1 | 2015 | 41 | 0.120 |
Why?
|
| Ulcer | 1 | 2015 | 38 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 328 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 313 | 0.120 |
Why?
|
| Carcinoid Tumor | 1 | 2015 | 45 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2019 | 601 | 0.120 |
Why?
|
| Treatment Outcome | 2 | 2020 | 8744 | 0.120 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2015 | 85 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2016 | 694 | 0.120 |
Why?
|
| Inflammation | 1 | 2020 | 1025 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 324 | 0.110 |
Why?
|
| Anesthesiology | 1 | 2016 | 159 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2024 | 1082 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2016 | 406 | 0.110 |
Why?
|
| Hepatectomy | 1 | 2015 | 176 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 812 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2017 | 900 | 0.110 |
Why?
|
| Combined Modality Therapy | 2 | 2022 | 1733 | 0.110 |
Why?
|
| Sex Factors | 1 | 2016 | 1095 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2022 | 4470 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 775 | 0.100 |
Why?
|
| Adenoma | 1 | 2015 | 255 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2015 | 964 | 0.100 |
Why?
|
| Intestine, Large | 1 | 2012 | 15 | 0.100 |
Why?
|
| Intestinal Fistula | 1 | 2012 | 31 | 0.100 |
Why?
|
| Feasibility Studies | 2 | 2024 | 800 | 0.100 |
Why?
|
| Abdominal Abscess | 1 | 2012 | 23 | 0.100 |
Why?
|
| Georgia | 2 | 2022 | 40 | 0.090 |
Why?
|
| Infliximab | 1 | 2012 | 161 | 0.090 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 219 | 0.090 |
Why?
|
| Hypertension | 1 | 2016 | 763 | 0.090 |
Why?
|
| Intestine, Small | 1 | 2012 | 301 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 246 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 3775 | 0.080 |
Why?
|
| Reoperation | 1 | 2012 | 654 | 0.080 |
Why?
|
| Recurrence | 1 | 2012 | 1180 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2009 | 215 | 0.070 |
Why?
|
| Immunologic Memory | 1 | 2009 | 177 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 1191 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 887 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 989 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 1150 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 1399 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 624 | 0.060 |
Why?
|
| Young Adult | 2 | 2020 | 6627 | 0.060 |
Why?
|
| Ergonomics | 1 | 2024 | 23 | 0.060 |
Why?
|
| Wrist | 1 | 2024 | 29 | 0.060 |
Why?
|
| Adolescent | 2 | 2020 | 9505 | 0.060 |
Why?
|
| Data Accuracy | 1 | 2024 | 32 | 0.050 |
Why?
|
| Risk Adjustment | 1 | 2023 | 40 | 0.050 |
Why?
|
| Accreditation | 1 | 2024 | 62 | 0.050 |
Why?
|
| Video Recording | 1 | 2024 | 205 | 0.050 |
Why?
|
| Biomechanical Phenomena | 1 | 2024 | 488 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2009 | 1592 | 0.050 |
Why?
|
| Syndrome | 1 | 2023 | 449 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2022 | 82 | 0.050 |
Why?
|
| Machine Learning | 1 | 2024 | 298 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2022 | 280 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2022 | 311 | 0.040 |
Why?
|
| Medical Audit | 1 | 2020 | 39 | 0.040 |
Why?
|
| Child | 1 | 2012 | 7334 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 36 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2020 | 236 | 0.040 |
Why?
|
| Financing, Government | 1 | 2019 | 24 | 0.040 |
Why?
|
| Federal Government | 1 | 2019 | 29 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 358 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 130 | 0.040 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 39 | 0.040 |
Why?
|
| Publishing | 1 | 2019 | 92 | 0.040 |
Why?
|
| General Surgery | 1 | 2020 | 238 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2018 | 98 | 0.030 |
Why?
|
| Elective Surgical Procedures | 1 | 2019 | 159 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 269 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 2729 | 0.030 |
Why?
|
| Pneumonia, Aspiration | 1 | 2015 | 19 | 0.030 |
Why?
|
| Rectal Diseases | 1 | 2015 | 23 | 0.030 |
Why?
|
| Registries | 1 | 2020 | 902 | 0.030 |
Why?
|
| Abscess | 1 | 2015 | 95 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 144 | 0.030 |
Why?
|
| Operative Time | 1 | 2015 | 158 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 490 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2684 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 5433 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 3513 | 0.020 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2009 | 14 | 0.020 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2009 | 40 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2009 | 100 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2009 | 133 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 103 | 0.020 |
Why?
|
| Sirolimus | 1 | 2009 | 174 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 209 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2009 | 468 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2009 | 2902 | 0.010 |
Why?
|
| Proteins | 1 | 2009 | 803 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 3360 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2009 | 1684 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 12110 | 0.010 |
Why?
|
| Animals | 1 | 2009 | 28017 | 0.010 |
Why?
|